Anticancer Research: 44 (12)

December 2024; Volume 44,Issue 12

Reviews

Open Access
Therapeutic Strategies in Neurocutaneous Melanocytosis
DIPANJAN BASU

Anticancer Research December 2024, 44 (12) 5157-5167; DOI: https://doi.org/10.21873/anticanres.17341
Open Access
The Multifaceted Role of Striatin-interacting Protein 2 (STRIP2) in Disease Pathogenesis and Cancer Progression
JABER H. JARADAT, GHAITH MASHARQA, RANEEM GHAZI AL-SHNAIKAT, MAYA MASHAL, AHMED M. AL-NUSAIRI and ANWAAR SAEED

Anticancer Research December 2024, 44 (12) 5169-5174; DOI: https://doi.org/10.21873/anticanres.17342

Experimental Studies

Open Access
HOOK3 Amplification in Bladder Urothelial Carcinoma: Insights from Gene Expression and Survival Analysis
JABER H. JARADAT, YASSINE ALAMI IDRISSI and ANWAAR SAEED

Anticancer Research December 2024, 44 (12) 5175-5185; DOI: https://doi.org/10.21873/anticanres.17343
Open Access
Exposure to Hypoxic Conditions Up-regulates HER2 in Breast Cancer Cell Lines
NOBUYASU SUGANUMA, NAO SAITO, MIO YASUKAWA, TAKASHI YAMANAKA, TOSHINARI YAMASHITA, YOHEI MIYAGI, AYA SAITO and DAISUKE HOSHINO

Anticancer Research December 2024, 44 (12) 5187-5192; DOI: https://doi.org/10.21873/anticanres.17344
Open Access
Synergistic Effects of Inecalcitol With Imatinib and Dasatinib on Chronic Myeloid Leukemia Cell Lines
SAMUEL ANGEL, EMMA COWLES, JEAMS COSTA, RAAD AL ANI and KALLIDAIKURICHI V. VENKATACHALAM

Anticancer Research December 2024, 44 (12) 5193-5197; DOI: https://doi.org/10.21873/anticanres.17345
Open Access
LET-7a and LET-7b as Potential Signatures for Glioma Recurrence, Regardless of WHO Tumor Grade
SYLVIE WEBER, SASKIA KUHL, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research December 2024, 44 (12) 5199-5205; DOI: https://doi.org/10.21873/anticanres.17346
Open Access
Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts
SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Anticancer Research December 2024, 44 (12) 5207-5213; DOI: https://doi.org/10.21873/anticanres.17347
Open Access
A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts
HISANOBU OGATA, AKIRA IMAIZUMI, YUTAKA FUJIOKA, HIROYUKI SHIMIZU, YUSUKE HIRATA, ATSUSHI MATSUZAWA, TOSHIHISA TSURUTA, HIROAKI NIIRO, HIDEYA ONISHI, MASAFUMI NAKAMURA and KENZABURO TANI

Anticancer Research December 2024, 44 (12) 5215-5218; DOI: https://doi.org/10.21873/anticanres.17348
Open Access
Investigation of Effectiveness of Nowarta110 Against Murine Malignant Melanoma in an Implanted Animal Model
JON SIN, MATEI KIOSEA, NICOLAE KIOSEA, KHOSROW MAHDAVI, FERRE AKBARPOUR, HONG-AN N. TRAN, BO HAN and BA X. HOANG

Anticancer Research December 2024, 44 (12) 5219-5224; DOI: https://doi.org/10.21873/anticanres.17349
Open Access
Impact of Warm Ischemia Time on HER2 Expression in Breast Cancer Surgical Specimens
NOBUYASU SUGANUMA, YUKA MATSUBARA, AKARI TAKAHASHI, TAKASHI YAMANAKA, TOSHINARI YAMASHITA, EMI YOSHIOKA, KAE KAWACHI, TOMONORI YOKOSE, HIROTO NARIMATSU, DAISUKE HOSHINO, YOHEI MIYAGI and AYA SAITO

Anticancer Research December 2024, 44 (12) 5225-5230; DOI: https://doi.org/10.21873/anticanres.17350
Open Access
MRTX1719, an MTA-cooperative PRMT5 Inhibitor, Induces Cell Cycle Arrest and Synergizes With Oxaliplatin and Gemcitabine for Enhanced Anticancer Effects
TOSHIHIRO SOETA, NORIHIKO SUGISAWA, AKIHIRO YAMAMURA, NAOKI TANAKA, HIROFUMI IMOTO, TAKAHIRO TSUCHIYA, TAKASHI AIZAWA, KOJI OKAMOTO, MARI KAWAMURA, FUMITO SAIJO, MASAMICHI MIZUMA, SHINOBU OHNUMA, TAKASHI KAMEI and MICHIAKI UNNO

Anticancer Research December 2024, 44 (12) 5231-5240; DOI: https://doi.org/10.21873/anticanres.17351
Open Access
Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma
MAKOTO FUJIWARA, TAKAHIRO MIMAE, KEI KUSHITANI, NORIFUMI TSUBOKAWA, YOSHIHIRO MIYATA, YUKIO TAKESHIMA and MORIHITO OKADA

Anticancer Research December 2024, 44 (12) 5241-5252; DOI: https://doi.org/10.21873/anticanres.17352
You have access
Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SHIGEKI SATO, HIROYUKI SAKAGUCHI, KOJI FUKUDA, HIROSHI KOTANI, AKIHIRO NISHIYAMA, SHIGEKI NANJO, KANAME YAMASHITA, SHINJI TAKEUCHI, SEIJI YANO, SAWAKO KURUMA, JUN NAKAHODO, MASATAKA KIKUYAMA and HIROAKI TANIGUCHI

Anticancer Research December 2024, 44 (12) 5253-5261; DOI: https://doi.org/10.21873/anticanres.17353
Open Access
Effects of ERK1/2 Inhibitors on the Growth of Acute Leukemia Cells
MAI ITOH and SHUJI TOHDA

Anticancer Research December 2024, 44 (12) 5263-5270; DOI: https://doi.org/10.21873/anticanres.17354
Open Access
Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer
ANNA HAYASHI, KOICHIRO KAMIO, AKIHIKO MIYANAGA, KEISUKE YOSHIDA, RINTARO NORO, KUNIKO MATSUDA, TAKEHIRO TOZUKA, MIWAKO OMORI, MARIKO HIRAO, AYA FUKUIZUMI, KAKERU HISAKANE, SUSUMU TAKEUCHI, MASARU MATSUMOTO, KAZUO KASAHARA, TAKANORI AMANO, KAZUFUMI HONDA and MASAHIRO SEIKE

Anticancer Research December 2024, 44 (12) 5271-5282; DOI: https://doi.org/10.21873/anticanres.17355
Open Access
Resveratrol Can Differentiate Human Melanoma Stem-like Cells from Spheroids Treated With All-trans Retinoic Acid
MINA KANAI, AKIHO SHINAGAWA, MASAKO OTA, NANTIGA VIRGONA and TOMOHIRO YANO

Anticancer Research December 2024, 44 (12) 5283-5292; DOI: https://doi.org/10.21873/anticanres.17356
You have access
Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma
HWAN HEE LEE, SEOYEON OH, HYOJEUNG KANG and HYOSUN CHO

Anticancer Research December 2024, 44 (12) 5293-5301; DOI: https://doi.org/10.21873/anticanres.17357
You have access
Enhancing Estimation Accuracy of Prostate Cancer VMAT Planning: A Knowledge-based Approach Using Multiple Collimator Angles
TATSUYA KAMIMA, YOSHIHIRO UEDA, JUN-ICHI FUKUNAGA, YUMIKO SHIMIZU, YASUO YOSHIOKA and HAJIME MONZEN

Anticancer Research December 2024, 44 (12) 5303-5312; DOI: https://doi.org/10.21873/anticanres.17358
You have access
Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors
YEHYEONG LEE, YONGHYO KIM, HYERAN SHIN, YEONG CHAN RYU, DONG-WOO KANG, TAE IL KIM and YONG-HEE CHO

Anticancer Research December 2024, 44 (12) 5313-5322; DOI: https://doi.org/10.21873/anticanres.17359
You have access
Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells
CHUN-YU FU, PEN-AN LIAO, TZU-HSIANG LIN, FEI-TING HSU, DAI-CHENG DONG and WEI-TING CHEN

Anticancer Research December 2024, 44 (12) 5323-5335; DOI: https://doi.org/10.21873/anticanres.17360
You have access
Regulation of Tumor Growth and Invasion in Oral Squamous Cell Carcinoma by the Tumor Microenvironment Through the Enhancement of IGFBP-3 Expression
DOKYEONG KIM, YOUNG JIN PARK and YOUNG SUN HWANG

Anticancer Research December 2024, 44 (12) 5337-5349; DOI: https://doi.org/10.21873/anticanres.17361
You have access
Effects of Curcumin and Its Analogue Desmethoxycurcumin on miR-133b and Its Target Gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells
ESİN BAYRALI ÜLKER, ESİN ÇETİN AKTAŞ, MEHMET FATİH SEYHAN, TURGAY İSBİR, DERYANAZ BİLLUR and ÖZLEM TİMİRCİ-KAHRAMAN

Anticancer Research December 2024, 44 (12) 5351-5359; DOI: https://doi.org/10.21873/anticanres.17362
You have access
Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis
FRANCISCO CEZAR AQUINO DE MORAES, MARIA EDUARDA CAVALCANTI SOUZA, EMANUELE ROCHA DA SILVA, MICHELE KREUZ and ROMMEL MARIO RODRIGUEZ BURBANO

Anticancer Research December 2024, 44 (12) 5361-5370; DOI: https://doi.org/10.21873/anticanres.17363
You have access
Taurine Protects Irinotecan-induced Muscle Dysfunction by Modulating Oxidative Stress and Endoplasmic Reticulum Stress in Human Skeletal Muscle Cells
CHIH-I CHEN, YU-CHI CHEN, YI-KAI KAO, CHIA-HUNG CHEN, PO-WEN YANG, PIN-CHUN CHEN, LING-CHIAO SONG and KAI LUNG TSAI

Anticancer Research December 2024, 44 (12) 5371-5378; DOI: https://doi.org/10.21873/anticanres.17364
You have access
Comprehensive Analysis of GJB1 in Breast Cancer: Its Implications in Survival and Molecular Mechanisms
ENGIN OZCIVICI and GULISTAN MESE

Anticancer Research December 2024, 44 (12) 5379-5391; DOI: https://doi.org/10.21873/anticanres.17365
You have access
Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma
SONEXAI KIDOIKHAMMOUAN, WORACHART LERT-ITTHIPORN, RAKSAWAN DEENONPOE, CHARUPONG SAENGBOONMEE, SUMALEE OBCHOEI, SOPIT WONGKHAM and WUNCHANA SEUBWAI

Anticancer Research December 2024, 44 (12) 5393-5404; DOI: https://doi.org/10.21873/anticanres.17366
You have access
Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
LIPING WEI, ZHAOYAN JIANG, SHUJUAN CHEN, NING XIA, JIEJUN KONG, YAN CHANG and ZHIBO HOU

Anticancer Research December 2024, 44 (12) 5405-5423; DOI: https://doi.org/10.21873/anticanres.17367
You have access
GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis
HONG-BEUM KIM, WOO YOUNG CHOI, SEONG-HUN KIM, HEE-JEONG LEE and SANG-GON PARK

Anticancer Research December 2024, 44 (12) 5425-5433; DOI: https://doi.org/10.21873/anticanres.17368
You have access
Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer
HYERAN SHIN, YONGHYO KIM, YEHYEONG LEE, JISOO KIM, YEONG CHAN RYU, DONG-WOO KANG, TAE IL KIM and YONG-HEE CHO

Anticancer Research December 2024, 44 (12) 5435-5443; DOI: https://doi.org/10.21873/anticanres.17369

Clinical Studies

Open Access
Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma
HARISH N. VASUDEVAN, ANN A. LAZAR, KEVIN REYES, DA RONG, SHAUN AREVALO, SCOT FEDERMAN, JASON W. CHAN, CHARLES Y. CHIU, STEVE MILLER and SUE S. YOM

Anticancer Research December 2024, 44 (12) 5445-5453; DOI: https://doi.org/10.21873/anticanres.17370
Open Access
Survival Outcomes and Disparities in Surgery Refusal for Papillary Thyroid Cancer
JADE C. BOWERS, BANSI P. SAVALIYA, SWATHI R. RAIKOT, SYEDA HOORULAIN AHMED, RAMIN SHEKOUHI, REED POPP, KYLE POPP, KULKAEW B. SUKNIAM, GABRIELLE KOWKABANY, PAOLA BERRIOS JIMENEZ, FATIMA MUBARAK, ESINAM P. EKPEH, SHIVAM BANSAL, SEEMA SHARAN, HARSHEEN K. MANAISE and EMMANUEL M. GABRIEL

Anticancer Research December 2024, 44 (12) 5455-5461; DOI: https://doi.org/10.21873/anticanres.17371
Open Access
Cryoablation for Malignant Bone and Soft Tissue Tumors and Histological Assessment of Ablated Tumors
KUNIHIRO ASANUMA, ATSUHIRO NAKATSUKA, TOMOKI NAKAMURA, MASASHI FUJIMORI, TAKASHI YAMANAKA, TOMOHITO HAGI, YUMI MATSUYAMA, TAKAHIRO IINO and MASAHIRO HASEGAWA

Anticancer Research December 2024, 44 (12) 5463-5476; DOI: https://doi.org/10.21873/anticanres.17372
Open Access
Impact of Radiation Dose on the Survival of Patients With Non-small Cell Lung Cancer Treated With Palliative Intent: Results of a Multicenter Prospective Study
VERONICA CAÑÓN, JOSE LUIS LÓPEZ-GUERRA, ANDER ARTEAGOITIA, OLGA DEL HOYO, FERNAN SUAREZ, DAVID BÜCHSER, ALFONSO GÓMEZ-ITURRIAGA, ARTURO NAVARRO-MARTIN, ROBERTO ORTIZ DE ZARATE, JOSE FERNANDO PÉREZ AZORÍN, DIRK RADES and JON CACICEDO

Anticancer Research December 2024, 44 (12) 5477-5484; DOI: https://doi.org/10.21873/anticanres.17373
Open Access
Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive Esophagectomy
RIKUYA TORIGOE, TARO OSHIKIRI, HIRONOBU GOTO, YASUHUMI KOTERAZAWA, RYUICHIRO SAWADA, TARO IKEDA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI

Anticancer Research December 2024, 44 (12) 5485-5493; DOI: https://doi.org/10.21873/anticanres.17374
You have access
Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC
CHARLOTTE TEGENBOSCH and KAROLIEN VEKENS

Anticancer Research December 2024, 44 (12) 5495-5500; DOI: https://doi.org/10.21873/anticanres.17375
Open Access
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice
AKIKO TATEISHI, YUSUKE OKUMA, YASUSHI GOTO, MOTOKO ARAKAKI, YUKIKO SHIMODA IGAWA, MASAHIRO TORASAWA, YUKI SHINNO, TATSUYA YOSHIDA, HIDEHITO HORINOUCHI, NOBORU YAMAMOTO and YUICHIRO OHE

Anticancer Research December 2024, 44 (12) 5501-5513; DOI: https://doi.org/10.21873/anticanres.17376
You have access
Immunohistochemical Expression and Significance of Preferentially Expressed Antigen in Melanoma (PRAME) in Gynecological Tumors: A Single-institution Retrospective Analysis
YUNJOO CHO and HYUN-SOO KIM

Anticancer Research December 2024, 44 (12) 5515-5524; DOI: https://doi.org/10.21873/anticanres.17377
You have access
Tissue Expression and Plasma Soluble PD-L1 Levels in Patients With Endometrial Cancer
EMMANUEL KONTOMANOLIS, ANTONIOS KOUTRAS, ACHILLEAS G. MITRAKAS, GRIGORIOS TRYPSIANIS, KONSTANTINOS NIKOLETTOS, PANAGIOTIS TSIKOURAS, NIKOLAOS NIKOLETTOS, ALEXANDRA GIATROMANOLAKI and MICHAEL KOUKOURAKIS

Anticancer Research December 2024, 44 (12) 5525-5530; DOI: https://doi.org/10.21873/anticanres.17378
You have access
Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
KENJIRO TSURUOKA, YOSUKE TAMURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA, SHIGERU KAWABATA, AKIHISA IMAGAWA and YASUHITO FUJISAKA

Anticancer Research December 2024, 44 (12) 5531-5539; DOI: https://doi.org/10.21873/anticanres.17379
You have access
Optimal Therapy for Postoperative Recurrence: Does Salvage Radiation Work for Locoregional Recurrence?
YURI TANIGUCHI, TAKAO SHIGENOBU, AKIKO HAYASHI, AYUMI HIRAHARA, KOTA ITO, HIROYUKI SHINOHARA, AYA SHIBA, YUKO HIGASHI, YUYA TABUCHI, TAKAHIRO SUZUKI, MASAHARU AGA, YUSUKE HAMAKAWA, KAZUHITO MIYAZAKI, MIZUKI SATO, YUKI MISUMI, YOKO AGEMI, YUKIKO NAKAMURA, TSUNEO SHIMOKAWA, KAZUMASA ODAGIRI, AKIRA YOSHIZU and HIROAKI OKAMOTO

Anticancer Research December 2024, 44 (12) 5541-5549; DOI: https://doi.org/10.21873/anticanres.17380
You have access
Perioperative Anemia Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, RYUKI ESASHI, SOSUKE YAMAMOTO, KIYOKO SHIMADA, KEISUKE KAZAMA, KOJI NUMATA, MAMORU UCHIYAMA, AYAKO TAMAGAWA, AYA SAITO and NORIO YUKAWA

Anticancer Research December 2024, 44 (12) 5551-5557; DOI: https://doi.org/10.21873/anticanres.17381
Open Access
Prognostic Significance of Innovative Inflammation-nutrition Biomarker Score in Patients With Colorectal Cancer
MASATSUNE SHIBUTANI, SHINICHIRO KASHIWAGI, HIDEKI TANDA, YUKI SEKI, KOJI TAKADA, HIROAKI KASASHIMA, TATSUNARI FUKUOKA and KIYOSHI MAEDA

Anticancer Research December 2024, 44 (12) 5559-5567; DOI: https://doi.org/10.21873/anticanres.17382
You have access
Prognostic Factors of Flap Complications After Carbon-ion Radiotherapy for Head and Neck Cancer With Reconstruction
HIROAKI IKAWA, MASASHI KOTO, TOKUHIKO OMATSU, SHURI AOKI, HIROTOSHI TAKIYAMA, TETSURO ISOZAKI, MAKOTO SHINOTO, REIKO IMAI, HIROSHI TSUJI and SHIGERU YAMADA

Anticancer Research December 2024, 44 (12) 5569-5576; DOI: https://doi.org/10.21873/anticanres.17383
You have access
Gallbladder Follicular Lymphoma Mimicking Gallbladder Cancer
TAKASHI NAKAGAKI, TOSHIRO MASUDA, YASUNORI NAGAYAMA, YOSHIHIRO KOMOHARA, HIROSHI TAKENO, HIDEAKI MIYAMOTO, TOSHIHIKO MOTOHARA, YUKI ADACHI, ERI ODA, RYUICHI KARASHIMA, TAKATOSHI ISHIKO and TORU BEPPU

Anticancer Research December 2024, 44 (12) 5577-5583; DOI: https://doi.org/10.21873/anticanres.17384
You have access
Case Report: Surgical Decompression With Subsequent Selumetinib Treatment Leads to Drastic Clinical Improvement in a Patient With a Large Spinal Plexiform Neurofibroma
TABEA I. HARTUNG, LAN KLUWE, FLORIAN BREMBACH, LENNART WELL, REINHARD E. FRIEDRICH, CATENA KRESBACH, MALTE MOHME and SAID C. FARSCHTSCHI

Anticancer Research December 2024, 44 (12) 5585-5590; DOI: https://doi.org/10.21873/anticanres.17385

Corrigenda

Open Access
Corrigenda
Anticancer Research December 2024, 44 (12) 5591-5592; DOI: https://doi.org/10.21873/anticanres.17386

Index

Open Access
Index
Anticancer Research December 2024, 44 (12) 5593-5757;

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

Corrigenda

Index

In this issue

Issue highlights

Jump to